Cancer-Associated Stroke: The Bergen NORSTROKE Study
Background: Underlying malignancy can cause ischemic stroke in some patients. Mechanisms include the affection of the coagulation cascade, tumor mucin secretion, infections and nonbacterial endocarditis. The release of necrotizing factor and interleukins may cause inflammation of the endothelial lin...
Main Authors: | Henriette Aurora Selvik, Lars Thomassen, Anna Therese Bjerkreim, Halvor Næss |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2015-10-01
|
Series: | Cerebrovascular Diseases Extra |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/440730 |
Similar Items
-
Intravenous Thrombolysis in Ischemic Stroke Patients With Active Cancer
by: Henriette Aurora Selvik, et al.
Published: (2018-09-01) -
Neonatal Arterial Ischemic Stroke Study
by: J Gordon Millichap
Published: (2012-01-01) -
Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study
by: Mi Ji Lee, et al.
Published: (2017-01-01) -
A Prothrombotic Score Based on Genetic Polymorphisms of the Hemostatic System Differs in Patients with Ischemic Stroke, Myocardial Infarction, or Peripheral Arterial Occlusive Disease
by: Juliane Herm, et al.
Published: (2017-06-01) -
Ischemic lesions in all territories as a marker of malignant hypercoagulability
by: Claus Z. Simonsen, et al.
Published: (2019-07-01)